Showing 1 - 9 of 9
We study determinants of COVID-19 vaccine donations from recipients' perspective, especially considering supply chain and institutional weakness (corruption) aspects. Results, based on data from more than 131 nations, show that strengthened supply chains reduced donations. The impacts of...
Persistent link: https://www.econbiz.de/10014393223
Persistent link: https://www.econbiz.de/10012656372
This paper adds some formal research to the success of ongoing efforts to combat the COVID-19 pandemic by examining the drivers of the administration and delivery efficiency of coronavirus vaccines. For this purpose, we use data from the 50 US states and place the formal analysis in the context...
Persistent link: https://www.econbiz.de/10012494792
Persistent link: https://www.econbiz.de/10012818094
Persistent link: https://www.econbiz.de/10012880057
This paper studies the propensities of the U.S. population to seek a full dose of vaccinations against the COVID-19 pandemic. Beyond the consideration of vaccine dissemination at the disaggregated or the local level, the main focus of this study is on determining whether a lack of health...
Persistent link: https://www.econbiz.de/10013482631
This paper compares drivers of full COVID-19 vaccinations and booster doses across U.S. counties. Booster doses are contingent upon someone receiving the primary doses, and the risk attitudes and propensities to get vaccinated may be different across individuals, along with the supply chain...
Persistent link: https://www.econbiz.de/10014313479
This paper studies the propensities of the U.S. population to seek a full dose of vaccinations against the COVID-19 pandemic. Beyond the consideration of vaccine dissemination at the disaggregated or the local level, the main focus of this study is on determining whether a lack of health...
Persistent link: https://www.econbiz.de/10014263166
This paper adds some formal research to the success of ongoing efforts to combat the COVID-19 pandemic by examining the drivers of the administration and delivery efficiency of coronavirus vaccines. For this purpose, we use data from the 50 US states and place the formal analysis in the context...
Persistent link: https://www.econbiz.de/10013235098